PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
29-Jun-2021 Vertex Announces New Portfolio Reimbursement Agreement in Italy Including KAFTRIO®, SYMKEVI® and Additional Indications of ORKAMBI® and KALYDECO® for Eligible Patients With Cystic Fibrosis Vertex
29-Jun-2021 Vertex Announces National Reimbursement Agreement in France for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) and SYMKEVI® (tezacaftor/ivacaftor) for Eligible Cystic Fibrosis Patients Vertex
29-Jun-2021 eTheRNA immunotherapies and Quantoom Biosciences Announce a Strategic Collaboration for the Development of a Novel RNA Production System eTheRNA immunotherapies
29-Jun-2021 Cell and Gene Therapy Catapult to expand to Edinburgh BioQuarter CGT Catapult
29-Jun-2021 Sanofi launches dedicated vaccines mRNA Center of Excellence Sanofi
29-Jun-2021 Five Arrows invests in Sygnature Discovery Sygnature Discovery
29-Jun-2021 BRIM Biotechnology’s lead candidate BRM421 for Dry Eye Syndrome shows promising results in Phase II clinical trials Sciad Newswire
29-Jun-2021 Genomics Market to Progress at a Healthy CAGR in Coming Years MarketsandMarkets Research Private Ltd.
29-Jun-2021 What is the In-vitro diagnostics market growth in the coming years? MarketsandMarkets Research Private Ltd.
29-Jun-2021 Adhesion Barrier Market to Reach USD 769 million by 2025 MarketsandMarkets Research Private Ltd.
29-Jun-2021 NGS-Based RNA-Sequencing Market to Reach USD 4.2 billion by 2024 MarketsandMarkets Research Private Ltd.
29-Jun-2021 Healthcare Analytical Testing Services Market to Reach USD 8.4 billion by 2025 MarketsandMarkets Research Private Ltd.
29-Jun-2021 DEFENCE THERAPEUTICS SIGNS A COLLABORATION AGREEMENT WITH THE CURIE INSTITUTE FOR TESTING THE ACCUM-T-DM1 ADC THERAPEUTIC IN PDX MODELS OF BREAST CANCER Defence Therapeutics Inc.
29-Jun-2021 Cannovum AG enters the full-spectrum cannabis extract market Cannovum AG
29-Jun-2021 Lonza Publishes Restated Financials for 2020 Lonza Group AG
29-Jun-2021 Relief and APR Applied Pharma Research Sign and Close Definitive Agreement for Relief to Acquire All Outstanding Shares of APR RELIEF THERAPEUTICS Holdings AG
29-Jun-2021 Formycon and Bioeq announce submission of the marketing authorization application for FYB201, a biosimilar candidate to Lucentis(R)1 (ranibizumab) to the European Medicines Agency (EMA) Formycon AG
28-Jun-2021 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Provides Update on Financial Guidance Vivoryon Therapeutics N.V.
28-Jun-2021 Vivoryon Therapeutics and Simcere Announce Strategic Regional Licensing Partnership to Develop and Commercialize N3pE Amyloid-targeting Medicines to Treat Alzheimer's Disease in Greater China Vivoryon Therapeutics N.V.
28-Jun-2021 Vivoryon Therapeutics N.V.: Ordinary General Meeting of Shareholders of Vivoryon Therapeutics N.V. Vivoryon Therapeutics N.V.